BioWorld

Aug. 3, 1995

View Archived Issues

SEPRACOR RAISES $55M IN PUBLIC OFFERING OF 4M SHARES

Read More

VIROPHARMA RAISES $7M IN INITIAL VENTURE FINANCING

Read More

APPLIED IMMUNE SELECTED FOR EXCLUSIVE TIL-CELL LICENSE

Read More

NIH BLAMED FOR CONTINUED DELAYS IN REVIEWING GENE THERAPY RESEARCH

Read More